Heparan Sulfate Plays a Central Role in a Dynamic in Vitro Model of Protein-losing Enteropathy

This publication has 32 references indexed in Scilit:

• A Proteoglycan Undergoes Different Modifications en Route to the Apical and Basolateral Surfaces of Madin-Darby Canine Kidney Cells
  Journal of Biological Chemistry, 2005
• Heparan sulfate depletion amplifies TNF-α-induced protein leakage in an in vitro model of protein-losing enteropathy
  American Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
• Gastrointestinal manifestations of postnatal cytomegalovirus infection in infants admitted to a neonatal intensive care unit over a five year period
  Archives of Disease in Childhood: Fetal & Neonatal, 2004
• Cloning and Characterization of Two Extracellular Heparin-degrading Endosulfatases in Mice and Humans
  Journal of Biological Chemistry, 2002
• Synergistic effects of interferon γ and tumour necrosis factor α on T84 cell function
  Gut, 1999
• Reversal of protein-losing enteropathy with heparin therapy in three patients with univentricular hearts and Fontan palliation
  The Journal of Pediatrics, 1997
• Disruption of sulphated glycosaminoglycans in intestinal inflammation
  The Lancet, 1993
• On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin.
  Journal of Clinical Investigation, 1991
• Interferon‐γ binds to heparan sulfate by a cluster of amino acids located in the C‐terminal part of the molecule
  FEBS Letters, 1991
• Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers.
  Journal of Clinical Investigation, 1989